A turn-on CRISPR/Cas12a strategy featuring a sterically-hindered activator for in situ fluorescence imaging of H2O2 in vivo
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.118449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Zhiqiang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing Un…. Hauptthemen laut MEDLINE: Hydrogen Peroxide, CRISPR-Cas Systems, Biosensing Techniques, Optical Imaging. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, State Key Laboratory of Analytical Chemistry for Life Science.
Abstract (Originalsprache)
Hydrogen peroxide (H2O2) serves as a key biomarker of oxidative stress in pathological processes such as cancer and inflammation. However, its in vivo visualization remains challenging due to the lack of sensitive, rapid, and bioorthogonal imaging methods. Here, we present a H2O2-activatable CRISPR/Cas12a strategy, termed A-BO-CRISPR, for real-time fluorescence imaging in living systems. This biosensing strategy employs a 4-bromomethylphenylboronic acid pinacol ester-caged DNA activator whose binding to crRNA is initially blocked by steric hindrance, effectively suppressing Cas12a trans-cleavage activity. Upon encountering endogenous H2O2, the boronate ester is selectively hydrolyzed, restoring activator/crRNA hybridization and triggering amplified fluorescent signal generation via Cas12a-mediated collateral cleavage of a ssDNA reporter. The system achieves a detection limit of 0.64 μM and responds within minutes, enabling real-time monitoring of H2O2 fluxes in living cells and tumor-bearing mice. It exhibits high selectivity and robust stability in complex biological environments. By integrating a chemical gating mechanism with CRISPR-based signal amplification, this work paves the way for potential applications in probing redox biology, imaging-guided diagnostics and therapeutic monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, 210023, China.
- School of Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun, 130022, China. Electronic address: 2024800080@cust.edu.cn.
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, 210023, China. Electronic address: jing15209791@nju…
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- State Key Laboratory of Analytical Chemistry for Life Science
- Jiangsu Province Natural Science Foundation
- Education Department of Jilin Province
- Nanjing University State Key Laboratory of Analytical Chemistry for Life Sciences
Zitieren
APA
Li, Z., Zhang, W., Feng, Z., Liu, Z., Feng, Z., Shi, Y., Zhan, J., & Zhang, J. (2026). A turn-on CRISPR/Cas12a strategy featuring a sterically-hindered activator for in situ fluorescence imaging of H2O2 in vivo. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.118449
Vancouver
Li Z, Zhang W, Feng Z, Liu Z, Feng Z, Shi Y, et al. A turn-on CRISPR/Cas12a strategy featuring a sterically-hindered activator for in situ fluorescence imaging of H2O2 in vivo. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.118449
BibTeX
@article{Li2026,
author = {Li, Zhiqiang and Zhang, Wenxian and Feng, Zhe and Liu, Zheng and Feng, Zhiyuan and Shi, Yang and Zhan, Jiayin and Zhang, Jingjing},
title = {A turn-on CRISPR/Cas12a strategy featuring a sterically-hindered activator for in situ fluorescence imaging of H2O2 in vivo},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.118449}
}
EUVIMED